Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $2.53 Million - $3.8 Million
70,045 New
70,045 $2.63 Million
Q2 2022

Aug 15, 2022

SELL
$36.95 - $82.41 $216,637 - $483,169
-5,863 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $201,299 - $526,885
3,614 Added 160.69%
5,863 $446,000
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $123,030 - $166,339
911 Added 68.09%
2,249 $335,000
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $1.13 Million - $1.49 Million
-7,750 Reduced 85.28%
1,338 $195,000
Q2 2021

Aug 16, 2021

BUY
$134.22 - $202.37 $1.22 Million - $1.84 Million
9,088 New
9,088 $1.78 Million
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $874,038 - $1.23 Million
-6,232 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $788,161 - $1.02 Million
6,232 New
6,232 $882,000
Q3 2020

Nov 16, 2020

SELL
$87.44 - $125.0 $27,805 - $39,750
-318 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$58.39 - $89.31 $18,568 - $28,400
318 New
318 $28,000
Q4 2019

Feb 14, 2020

SELL
$46.07 - $79.54 $277,756 - $479,546
-6,029 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$49.99 - $62.0 $301,389 - $373,798
6,029 New
6,029 $304,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.42B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.